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ABSTRACT 52 
Tubulinopathies are increasingly emerging major causes underlying complex cerebral 53 
malformations, particularly in case of microlissencephaly often associated with hypoplastic or 54 
absent corticospinal tracts. Fetal akinesia deformation sequence (FADS) refers to a clinically 55 
and genetically heterogeneous group of disorders with congenital malformations related to 56 
impaired fetal movement.57 
We report on an early foetal case with FADS and microlissencephaly due to TUBB2B58 
mutation. Neuropathological examination disclosed virtually absent cortical lamination, foci 59 
of neuronal overmigration into the leptomeningeal spaces, corpus callosum agenesis, 60 
cerebellar and brainstem hypoplasia and extremely severe hypoplasia of the spinal cord with 61 
no anterior and posterior horns and almost no motoneurons. 62 
At the cellular level, the p.Cys239Phe TUBB2B mutant leads to tubulin heterodimerization 63 
impairment, decreased ability to incorporate into the cytoskeleton, microtubule dynamics 64 
alteration, with an accelerated rate of depolymerization. 65 
To our knowledge, this is the first case of microlissencephaly to be reported presenting with a 66 
so severe and early form of FADS, highlighting the importance of tubulin mutation screening 67 
in the context of FADS with microlissencephaly. 68 
69 
70 
71 
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microlissencephaly, microcephaly, migration disorder, TUBB2B, Fetal akinesia deformation 73 
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INTRODUCTION 75 
Normal fetal development is dependent on adequate fetal movement, starting at 8 weeks of 76 
gestation (WG). Limitation of movements results in fetal akinesia deformation sequence 77 
(FADS; OMIM 208150). FADS was first reported as a syndrome by Pena and Shokeir in 78 
1974 and further delineated as a symptom by Hall in 1981 [1,2]. Its incidence varies among 79 
different countries and has been estimated at 1:3000 to 1:5000 by Fahy and Hall [3]. The 80 
clinical presentation is highly variable, ranging from the most severe form called lethal 81 
multiple pterygium syndrome characterized by multiple joint contractures and pterygia, lung 82 
hypoplasia, short umbilical cord, craniofacial changes consisting of hypertelorism, 83 
micrognathism, cleft palate, short neck, low-set ears, along with intrauterine growth 84 
retardation and abnormal amniotic fluid volume mainly observed from the first trimester of 85 
the pregnancy [4]. Less severe phenotypes may present either as distal arthrogryposis or as 86 
fetal hypomotility which usually occurs during the third trimester [5].  87 
Non-genetic factors may cause FADS, such as environmental limitation of fetal movements, 88 
maternal infection, drugs and immune mechanisms (maternal autoimmune myasthenia). The 89 
FADS phenotype is observed in a number of known genetic syndromes. Non syndromic or 90 
isolated FADS is genetically heterogeneous and encompass multiple neurogenic processes 91 
affecting the central or the peripheral nervous system, the neuromuscular junction and the 92 
skeletal muscle [6-8]. Until recently, the neurogenic form characterized by spinal cord 93 
motoneuron paucity, either isolated or associated with pontocerebellar hypoplasia was 94 
considered as the most frequent cause [9-11]. Conversely, brain malformations are very 95 
infrequently observed in association with FADS, and mainly described in lissencephalies type 96 
I and II as deformations of the extremities [12,13]. To our knowledge, FADS has never been 97 
reported in association with tubulin related cortical malformations. Here, we report on the 98 
most severe presentation of tubulinopathy in a fetus harboring a de novo missense mutation in 99 
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the ȕ-tubulin gene TUBB2B gene (MIM 615101), along with neuropathology and molecular 100 
data focusing on the consequences of the mutation, that could explain at least partly the 101 
severity of the lesions and early fetal presentation.102 
PATIENT AND METHODS103 
Case history 104 
A 32-year-old woman, gravida 4, para 3, underwent routine ultrasonography (US) at 12 WG, 105 
which revealed severe fetal akinesia. Control ultrasound examination performed at 14 WG 106 
confirmed total lack of movements, retrognathia and dilatation of the third and fourth cerebral 107 
ventricles (supplementary figure 1). A medical termination of the pregnancy was achieved at 108 
15 WG, in accordance with French law. A complete autopsy was performed with informed 109 
written consent from both parents. Brain lesions identified at autopsy suggested a possible 110 
Walker Warburg syndrome (WWS) despite absent eye lesions, so that a first-line screening of 111 
WWS genes was performed, but was negative. Indeed, known environmental causes of FADS 112 
were excluded, as well as syndromic causes. Chromosomal analysis performed on trophoblast 113 
biopsy revealed a normal male karyotype, 46, XY. The parents were non consanguinous and 114 
there was no relevant personal or family history. Three children born to a previous marriage 115 
were in good health.  116 
After having obtained written informed consent from the parents, DNAs were purified from 117 
fetal lung tissues, and from peripheral blood cells in both parents by using a standard 118 
phenol/chloroform method. Mutation analysis was performed by PCR amplification and 119 
direct SANGER sequencing of all coding exons and splice sites of the TUBB2B gene revealed 120 
a de novo missense mutation in exon 4, c.716G>T determining a p.Cys239Phe substitution 121 
(previously reported in [14]). No other variant was identified after sequencing of the other 122 
genes involved in cortical malformations.  123 
Neuropathological evaluation 124 
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Tissues including the brain, eyes and spinal cord were fixed in a 10% formalin-zinc buffer 125 
solution. Seven-micrometer sections obtained from paraffin-embedded tissues were stained 126 
using Haematoxylin-Eosin. Adjacent brain and spinal cord sections were assessed for routine 127 
immunohistochemistry, using antibodies directed against vimentin (diluted 1:100; Dakopatts, 128 
Trappes, France), calretinin (1:200; Zymed Clinisciences, Montrouge, France), and MAP2 129 
(diluted 1:50, Sigma, St Louis, MO). Immunohistochemical procedures included a microwave 130 
pre-treatment protocol to aid antigen retrieval (pretreatment CC1 kit, Ventana Medical 131 
Systems Inc, Tucson AZ). Incubations were performed for 32 minutes at room temperature 132 
using the Ventana Benchmark XT system. After incubation, slides were processed by the 133 
Ultraview Universal DAB detection kit (Ventana). All immunolabellings were compared with 134 
an age matched control case examined after a spontaneous abortion for premature rupture of 135 
the membranes, and whose brain was histologically normal. 136 
Functional analyses 137 
Protein modeling 138 
A model of human ȕ-tubulin was built by homology modeling using available structures 139 
(Research Collaboratory for Structural Bioinformatics PDB code 1TUB) from Nogales et al. 140 
[15]. The images in Figure 4C were rendered using PyMOL software 141 
(http://www.pymol.org).142 
Cloning and in vitro translation  143 
TUBB2B sequence was generated by PCR using a template from the human brain cDNA 144 
library (Clontech, Mountain View, CA). The PCR product was cloned into the pcDNA 3.1-145 
V5-His vector (Invitrogen, Carlsbad, CA) and checked by DNA sequencing. These products 146 
were cloned both into the cDNA3.1-V5-his-TOPO-TA cloning vector (Invitrogen) and pET 147 
vector. An in-frame tag encoding the FLAG epitope (DYKDDDDK) was incorporated by 148 
PCR along with the C-terminus of the TUBB2B wild-type sequence allowing for the 149 
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distinction of the transgene from other highly homologous endogenously expressed ȕ-tubulin 150 
polypeptides. The p.Cys239Phe mutation was introduced by site-directed mutagenesis using a 151 
QuikChange II kit (Stratagene, La Jolla, CA) and verified by DNA sequencing. 152 
Transcription/translation reactions were performed at 30°C for 90 min in 25 μl of rabbit 153 
reticulocyte lysate (TNT; Promega, Madison, WI) containing 35S-methionine (specific 154 
activity, 1000 Ci/μmol; 10 μCi/μl). For the generation of labelled ȕ-tubulin heterodimers, 155 
transcription/translation reactions were chased for a further 2 h at 30°C by the addition of 156 
0.375 mg/ml of native bovine brain tubulin. Aliquots (2 μl) were withdrawn from the 157 
reaction, diluted into 10 μl of gel-loading buffer (gel running buffer supplemented with 10% 158 
glycerol and 0.1% bromophenol blue) and stored on ice prior to resolution on a non-159 
denaturing gel. Labeled reaction products were detected by autoradiography after resolution 160 
on either SDS–PAGE or on native polyacrylamide gels as described [16,17].  161 
Cell cultures, transfections and immunofluorescence162 
Primary cultures of fibroblasts were derived from fibroblastic cells extracted from amniotic 163 
liquid. COS7 and Hela cells were transfected by construct with p.Cys239Phe TUBB2B 164 
mutation using the Fugene 6 transfection reagent (Roche Applied Science, Indianapolis, IN) 165 
and grown on glass cover slips in Dulbecco's modified Eagle's medium containing 10% fetal 166 
calf serum and antibiotics. The cells were fixed with ice-cold methanol, 24–48h after growth. 167 
In the depolymerization experiments used to determine the behavioural stability of 168 
microtubules after 24 h of culture, fibroblasts were incubated for various brief intervals from 169 
0 to 30 min on ice and fixed thereafter. Repolymerization experiments were performed by 170 
successively exposing cells at 4°C during 30mn and fixed after being incubated from 0 to 15 171 
min at 37°C. Cells were then labelled with a polyclonal anti-FLAG antibody (1/500), or a 172 
monoclonal anti-Į-tubulin antibody (1/1000) (Sigma-Aldrich Inc., St Louis, MO). At each 173 
experimental point, two parameters were quantified using ImageJ software: (i) the total area 174 
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of the cell and (ii) the area of the microtubules network of each cell, evaluated by 175 
quantifying the alpha-tubulin staining into the cytoskeleton and excluding the staining 176 
background corresponding to unincorporated alpha tubulin into the cellular cytoplasm. The 177 
ratio Microtubules Area/Total cell Area was used to evaluate the state of the microtubule 178 
network of the patient and control cells at each time point of 179 
depolymerisation/repolymerization experiments. 180 
181 
182 
RESULTS 183 
General autopsy findings 184 
The fetus weighed 47g (50thcentile). External examination disclosed cranio-facial 185 
dysmorphism with microretrognathia and  cleft palate due to akinesia (supplementary figure 186 
2), global amyotrophy and microcephaly (Figure 1A). No internal visceral malformation was 187 
found, except for the lungs which were hypoplastic, and the renal pelvis which was dilated. 188 
Neuropathological studies 189 
Macroscopically, the brain appeared to be small, weighting 2.15g (5th centile, normal weight 190 
= 10g according to Guilhard-Costa and Larroche [18]). Occipito-frontal length was 21mm and 191 
transverse diameter of the cerebellum was 0.17 mm (25th centile). The brain surface was 192 
smooth, covered by thickened leptomeninges adherent to the brain (Figure 1B). Olfactory 193 
tracts were absent and the meninges seemed fused (Figure 1C). On brainstem sections, the 194 
fourth ventricle was dilated and the cerebellum seemed hypoplastic and dysplastic, 195 
resembling the cerebellar dysplasia observed in Walker Warburg syndrome (Figure 1D). 196 
Macroscopic examination of serial coronal sections confirmed the dilatation of the third and 197 
lateral ventricles, the latter being filled with congestive choroid plexuses. 198 
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Histological examination of the eyes revealed no retinal dysplasia. The spinal cord displayed 199 
major lesions consisting of severe hypoplasia and immaturity (Figure 2A). Ascending and 200 
descending tracts were missing. Anterior and posterior horns were hardly discernible, with 201 
almost no motoneurons in the anterior horns, even using MAP2 antibodies (data not shown) 202 
(Figure 2B). The cerebral mantle was particularly thin, and cortical lamination was absent, 203 
rather forming an extremely disorganized two-layered cortex extending from the inferior limit 204 
of the marginal zone to the periventricular zone with no recognizable intermediate zone 205 
(Figure 2C). Layer I was irregular in width and contained isolated or small foci of immature 206 
neurons, as well as misplaced Cajal-Retzius cells immunolabeled by calretinin antibody lying 207 
under the pial basal membrane (Figure 2D). Underneath, a single band of neurons with a 208 
vague nodular or columnar organization was found, extending to the periventricular areas 209 
(Figure 2E). The cerebral mantle was covered by fibrous meninges containing multiple 210 
dysplastic tortuous vessels with dispersed overmigrating immature neurons (Figure 2F). 211 
Vimentin immunohistochemistry showed an irregular and fragmented glia limitans (Figure 212 
3A and B), with small gaps through which neurons overmigrated into the leptomeningeal 213 
spaces (Figure 3C, D). Vimentin immunohistochemistry also revealed severe abnormalities of 214 
the radial glia, which virtually absent in the cortical plate and entirely disorganized in the 215 
subventricular zone (Figure 3E and F).  216 
Functional analyses 217 
Consequences of the mutation on secondary and tertiary TUBB2B structures 218 
The p.Cys239 residue is located in the intermediary domain (amino acid 205–381) of the 219 
TUBB2B protein and is highly conserved during evolution among TUBB2B homologues 220 
from other species (Figure 4A). Tridimensional modeling analysis of TUBB2B using PYmol 221 
software displayed an inside localization of the variant in an helix closed to the Taxol fixation 222 
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site, apparently affecting neither the GDP binding pocket nor the Į/ȕ interacting region 223 
(Figure 4B). 224 
Alteration of Į/ȕ heterodimerization process and microtubules incorporation by TUBB2B 225 
variant 226 
To further investigate functional consequences of the mutation, the ȕ-tubulin mutant was 227 
expressed in rabbit reticulocyte lysate and its ability to assemble into Į/ȕ heterodimers in the 228 
presence of bovine brain tubulin was evaluated. The p.Cys239Phe mutant was translated as 229 
efficiently as the wild-type control (Figure 5A). However, analysis of the same reaction 230 
products under native conditions revealed a range of heterodimer formation that was 231 
significantly decreased both quantitatively and qualitatively in the case of p.Cys239Phe 232 
mutant compared to the wild-type control (Figure 5B) revealing an impairment of tubulin 233 
heterodimerization processes in the p.Cys239Phe mutant. 234 
Furthermore, the transfection of the flag-tagged p.Cys239Phe TUBB2B-mutated construct in 235 
COS7 and HeLa cells revealed both a detectable incorporation of the protein into 236 
microtubules and in contrast to controls, a diffuse high background of label that reflects 237 
presence of unpolymerized cytosolic tubulin heterodimers , suggesting a partial impairment of 238 
the remaining heterodimer ability to incorporate into the cytoskeleton (Figure 5C). 239 
Effects of p.Cys239Phe TUBB2B mutation on the dynamical microtubule behavior in fetal 240 
fibroblasts 241 
In order to assess the behavior of the microtubules in vivo, we analyzed the response of the 242 
cytoskeleton to cold-induced depolymerization treatment followed by a repolymerization step 243 
at 37°C in fibroblasts extracted from amniotic liquid from control and affected patient. 244 
Following cold-induced depolymerization, TUBB2B p.Cys239Phe displayed a normal rate of 245 
microtubules disintegration (Figure 5C). However, repolymerization experiments, consisting 246 
in a completed cytoskeleton depolymerization at 4°C and a gradual repolymerisation at 37°C, 247 
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revealed that p.Cys239Phe TUBB2B mutant microtubules are more repolymerized after 248 
5min at 37°C than controls (Figure 5C). These experiments show that with p.Cys239Phe 249 
mutant, the repolymerization rate to renew its cytoskeleton network is accelerated, provoking 250 
a defect of the depolymerization/repolymerization balance necessary for a proper dynamic 251 
behaviour of microtubules. 252 
DISCUSSION 253 
We report here the first case of Fetal Akinesia Deformation Sequence with 254 
microlissencephaly related to TUBB2B mutation, expanding the phenotype of ever-growing 255 
family of tubulin associated malformations. The diagnosis of FADS can be approached 256 
algorithmically, based on the presence of neurological symptoms and associated features 257 
[19,6]. Developmental abnormalities affecting the forebrain (e.g., hydranencephaly, 258 
microcephaly, or forebrain neuronal migration disorders), either due to primary genetic 259 
factors or to a consequence of fetal central nervous system infection or vascular insult, are 260 
sometimes associated with arthrogryposis [6 ,20]. In such cases, joint contractures are thought 261 
to be related to diminished corticospinal tract activation of spinal cord motor neurons. 262 
Sometimes, however, the underlying disease also directly affects spinal cord motor neurons, 263 
contributing to fetal akinesia or hypomotility. In addition to these classical causes, our report 264 
demonstrates that tubulin related microlissencephaly should be considered within the 265 
algorithm for diagnosis.  266 
Microlissencephaly is a rare entity characterized by severe congenital microcephaly with 267 
absent sulci and gyri leading most of the time to an early fatal outcome during the foetal or 268 
the neonatal period. We have previously underlined the importance of microlissencephaly in 269 
the spectrum of tubulinopathies [14]. There are emerging molecular data to suggest that 270 
NDE1 mutations [21,22] and more recently KATNB1 mutations [23] are involved in the 271 
autosomal recessive forms. Tubulin mutations, particularly TUBA1A and less frequently 272 
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TUBB2B and TUBB3 are significant causes of sporadic cases of microlissencephaly. 273 
Tubulin related microlissencephaly share common features consisting in corpus callosum 274 
agenesis, extremely reduced or absent cortical plate, hypertrophic germinal zones and 275 
ganglionic eminences, hypoplastic and disorganized striatum and thalami. In our case, the 276 
striatum and thalami were absent, along with germinative zones in which radial glial cells and 277 
radial glia had early disappeared, representing the most severe end of the spectrum. At the 278 
infratentorial level, our case also showed common signs of tubulin related 279 
microlissencephaly, i.e. severe cerebellar and brainstem hypoplasia, axon tract defects with 280 
absent corticospinal tracts. To our knowledge, 13 foetal cases with tubulin related 281 
microlissencephaly [14,24] and 4 living patients [24,25] have been reported so far. Of these, 8 282 
exhibited non specific dysmorphic features including retrognathia and hypertelorism, as well 283 
as adducted thumbs, extremely long fingers, and rocker bottom feet related to poor fetal 284 
mobility. The case reported here represents the extreme severe end of the spectrum due to 285 
extremely severe spinal cord hypoplasia with absent anterior and posterior horns and virtually 286 
indiscernible motoneurons at the histological level. In this context, fetal akinesia deformation 287 
sequence undoubtedly represents a neurogenic form, reminiscent of akinesia observed in 288 
Spinal Muscular Atrophy or fetal Pontocerebellar Hypoplasia type 1 [9-11]. 289 
The precise molecular function of TUBB2B in cortical development still remains unclear. Our 290 
analysis suggests that the aminoacid substitution in the p.Cys239Phe TUBB2B mutant leads 291 
to an impairment of tubulin heterodimerization processes and heterodimer ability to 292 
incorporate into the cytoskeleton. Morever, this mutant alters the microtubule dynamics with 293 
an accelerated rate of repolymerization, that is has been also predicted with another TUBB2B294 
related microlissencephaly mutation (p.Asp249His) [26]. In the literature, we already 295 
demonstrated that two TUBA1A and TUBB2B mutants’ cells p.Pro263Thr and p.Ser172Pro, 296 
respectively) display an opposite phenotype consisting of a defect to renew their cytoskeleton 297 
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network after total depolymerization, we assume that the two types of repolymerization 298 
impairments lead to abnormalities of the depolymerization/repolymerization balance 299 
necessary for a proper dynamic behaviour of microtubules [27 ,28]. As suggesting in the 300 
literature, a default in microtubules dynamics could lead to dramatic impairments of a 301 
numerous cellular processes including proliferation, migration and differentiation that are 302 
crucial steps for the brain development [28 ,29 ,30]. Therefore, we assume that this alteration 303 
of microtubule dynamics might affect brain and spinal cord development at distinct 304 
developmental steps, i.e. neurogenesis, neuronal migration and long tract formation, leading 305 
to the association of FADS and microlissencephaly. According to structural molecular 306 
models, the mutant p.Cys239Phe is predicted to alter tubulin folding. This extreme phenotype 307 
contrasts with our previous observations in which tubulin mutations predicted to impair 308 
tubulin folding but tended to be associated with milder cortical malformations [26] and 309 
emphasizes on the fact that comprehensive overview of tubulinopathies spectrum will require 310 
further investigations, including understanding of spatial and temporal consequences of 311 
tubulin mutations on MT-dependent cellular functions and early neuro-developmental 312 
processes. 313 
In conclusion, this fetal case recapitulates the phenotypic features of tubulin related 314 
microlissencephaly expands the phenotype due to early severe arthrogryposis and underlines 315 
the importance of considering tubulin gene TUBB2B in the diagnosis of arthrogryposis with 316 
microlissencephaly. 317 
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LEGENDS TO THE FIGURES 438 
439 
Figure 1: Macroscopical findings 440 
A. Severe foetal akinesia sequence with multiple deformations, joint contractures and 441 
pterygia, along with severe global amyotrophy 442 
B. Superior view of the brain exhibiting a cobblestone-like appearance with abnormal 443 
meningeal vessels 444 
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C. Inferior view of the brain displaying absent interhemispheric fissure due to fusion of the 445 
meninges, absent olfactory bulbs and tracts and severely hypoplastic cerebellum 446 
D. With absent foliation and almost indiscernible vermis and cerebellar hemispheres. 447 
448 
Figure 2: Main histological lesions 449 
A. Severe hypoplasia of the spinal cord (arrow) (H& E stain, OMx25) 450 
B. With at higher magnification, absent descending (arrow) and ascending tracts (triangle) 451 
and no motoneurons in the anterior horns (H& E stain, OMx250) 452 
C. Global disorganization of the cerebral mantle with no recognizable cortical plate, 453 
intermediate and germinal zones (H& E stain, OMx25)454 
D. Calretinin immunohistochemistry showing aberrant Cajal Retzius cell location, with focal 455 
accumulation of these cells along the persisting glia limitans instead of forming a continuous 456 
streak located at the upper third of the molecular layer (OMx100) 457 
E. Microscopic view of the cortical plate displaying thickened leptomeninges with tortuous 458 
vessels, only a minority of them properly penetrating into the brain parenchyma (arrow) (H& 459 
E stain, OMx100) 460 
F. Absent lamination of the cortical plate replaced by nodules or columns of neurons, some of 461 
them overmigrating into the leptomeningeal spaces (arrow) (H& E stain, OMx250) 462 
463 
Figure 3: Vimentin immunohistochemical studies 464 
A. Irregular thickening of the meninges (OMx100) 465 
B. Compared with an age-matched control brain (OMx100) 466 
C. With immature neurons accumulating just under the fragmented glia limitans (arrow) and 467 
disorganized vascular network (OMx250) 468 
D. With abnormal fibrous walls (arrow) and absent radial glia (OMx400) 469 
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E. And paucity of radial glial cells( arrow) and fragmentation of the radial glia in the  470 
subventricular zone (OMx400) 471 
F. Compared to an age-matched control brain where the neuroepithelium (arrow) and the 472 
subventricular zone are strongly immunolabeled (OMx400) 473 
H&E: Haematoxylin and eosin, OM: original magnification 474 
475 
Figure 4: TUBB2B de novo missense mutation (p.Cys239Phe) responsible of the phenotype 476 
FADS with microlissencephaly.  477 
A. Pedigree of the family and chromatograms showing the de novo occurrence of the 478 
TUBB2B p.Cys239Phe mutation. Square, male; round, female; diamond, fetus. Black colour, 479 
affected individual. 480 
B. Evolution conservation of the p.Cys239 amino acid in orthologues from stickleback to 481 
human. C. Structural representation using Pymol software of the Į/ȕ heterodimer depicted 482 
without (top left) or with (top right) surface delimitation. p.Cys239 amino acid (in green) is 483 
localized into an helix inside the monomer but outside GTP, GDP and taxol binding sites 484 
(detailed view, bottom). Pdb: 1TUB. 485 
486 
Figure 5: Defects in the Į/ȕ heterodimerisation process in the microtubule incorporation and 487 
dynamical behaviour in COS7 and fibroblasts expressing the p.Cys239Phe mutation. 488 
A. The p.Cys239Phe TUBB2B mutation results in inefficient Į/ȕ heterodimer formation in 489 
vitro. Analysis by SDS-Page and non denaturing gel of in vitro translation products conducted 490 
with 35S methionine labeled wild type and p.Cys239Phe mutant. The reaction products were 491 
further chased with bovine brain tubulin to generate Į/ȕ heterodimers. SDS-Page gel showed 492 
that the mutant was translated as efficiently as the wild type control. Note that in non 493 
denaturing gel condition, p.Cys239Phe mutant generated heterodimers in a diminished yield. 494 
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B. Expression of C-terminal Flag tagged TUBB2B wild type (left column) and 495 
p.Cys239Phe mutant (right column) in transfected COS7 cells revealed by antiflag (top line) 496 
and Į-tubulin (bottom line) staining. Note that a part of p.Cys239Phe mutant proteins failed to 497 
incorporate into the microtubule network, producing a more diffuse cytosolic labeling pattern 498 
in comparison with WT TUBB2B.  499 
C. In vivo analysis of cytoskeleton behaviour and stability using patient’s fibroblasts from 500 
amiotic liquid. Evaluation of the sensitivity of microtubules to cold treatment and of its ability 501 
to repolymerize was analyzed in control fibroblasts and patient fibroblasts with p.Cys239Phe 502 
mutation after 8 min of cold treatment at 4°C (left graph) or after 20 min at 4°C and 5 min at 503 
37°C (right graph). Note that the fibroblasts of the fetus correctly reacted to cold treatment by 504 
showing an increase in capacity to repolymerize compared to the wild type control.505 
506 
Supplementary figures 507 
Supplementary figure 1: US examination performed at 14 WG showing fetal (A) retrognathia 508 
and dilatation of the fourth cerebral ventricle (B)509 
510 
Supplementary figure 2: Fetal examination displaying arthrogryposis with clenched hands 511 
(A), posterior cleft palate (B), antebrachial C) and axillary pterygia (D).  512 
513 
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